The recent review by Van Der Linden et al. concludes "that data in the peer reviewed literature do not suggest an adverse safety signal" when tetrastarch is used perioperatively. The review as acknowledged by the authors was commissioned by a tetrastarch manufacturer. However, the unfortunate timing of publication immediately after publication of the Crystalloid Versus Hydroxyethyl Starch Trial may lead readers to underestimate safety concerns related to use of hydroxyethyl starches (HESs) in surgical patients. Major trials purely in the surgical setting are still lacking
展开▼
机译:Van Der Linden等人最近的评论。得出结论,围手术期使用四淀粉时,“同行评议文献中的数据没有暗示不利的安全信号”。作者的认可是由四淀粉制造商委托进行的。但是,不幸的是在《晶体学》和《羟乙基淀粉》试验发表后立即发表,这可能会使读者低估与在手术患者中使用羟乙基淀粉(HES)有关的安全性问题。仍缺乏纯粹在外科手术环境中进行的重大试验
展开▼